GIT2-A keystone in ageing and age-related disease.


Journal Article (Review)

Since its discovery, G protein-coupled receptor kinase-interacting protein 2, GIT2, and its family member, GIT1, have received considerable interest concerning their potential key roles in regulating multiple inter-connected physiological and pathophysiological processes. GIT2 was first identified as a multifunctional protein that is recruited to G protein-coupled receptors (GPCRs) during the process of receptor internalization. Recent findings have demonstrated that perhaps one of the most important effects of GIT2 in physiology concerns its role in controlling multiple aspects of the complex ageing process. Ageing can be considered the most prevalent pathophysiological condition in humans, affecting all tissue systems and acting as a driving force for many common and intractable disorders. The ageing process involves a complex interplay among various deleterious activities that profoundly disrupt the body's ability to cope with damage, thus increasing susceptibility to pathophysiologies such as neurodegeneration, central obesity, osteoporosis, type 2 diabetes mellitus and atherosclerosis. The biological systems that control ageing appear to function as a series of interconnected complex networks. The inter-communication among multiple lower-complexity signaling systems within the global ageing networks is likely coordinated internally by keystones or hubs, which regulate responses to dynamic molecular events through protein-protein interactions with multiple distinct partners. Multiple lines of research have suggested that GIT2 may act as one of these network coordinators in the ageing process. Identifying and targeting keystones, such as GIT2, is thus an important approach in our understanding of, and eventual ability to, medically ameliorate or interdict age-related progressive cellular and tissue damage.

Full Text

Cited Authors

  • van Gastel, J; Boddaert, J; Jushaj, A; Premont, RT; Luttrell, LM; Janssens, J; Martin, B; Maudsley, S

Published Date

  • May 2018

Published In

Volume / Issue

  • 43 /

Start / End Page

  • 46 - 63

PubMed ID

  • 29452267

Pubmed Central ID

  • 29452267

Electronic International Standard Serial Number (EISSN)

  • 1872-9649

International Standard Serial Number (ISSN)

  • 1568-1637

Digital Object Identifier (DOI)

  • 10.1016/j.arr.2018.02.002


  • eng